coin-img-ETHETH-2.23%coin-img-BTCBTC-2.66%coin-img-SOLSOL-3.23%coin-img-XRPXRP-3.83%coin-img-USDCUSDC+0.01%coin-img-HYPEHYPE+6.16%coin-img-SUISUI-3.82%coin-img-TONCOINTONCOIN+2.48%coin-img-ETHETH-2.23%coin-img-BTCBTC-2.66%coin-img-SOLSOL-3.23%coin-img-XRPXRP-3.83%coin-img-USDCUSDC+0.01%coin-img-HYPEHYPE+6.16%coin-img-SUISUI-3.82%coin-img-TONCOINTONCOIN+2.48%coin-img-ETHETH-2.23%coin-img-BTCBTC-2.66%coin-img-SOLSOL-3.23%coin-img-XRPXRP-3.83%coin-img-USDCUSDC+0.01%coin-img-HYPEHYPE+6.16%coin-img-SUISUI-3.82%coin-img-TONCOINTONCOIN+2.48%coin-img-ETHETH-2.23%coin-img-BTCBTC-2.66%coin-img-SOLSOL-3.23%coin-img-XRPXRP-3.83%coin-img-USDCUSDC+0.01%coin-img-HYPEHYPE+6.16%coin-img-SUISUI-3.82%coin-img-TONCOINTONCOIN+2.48%

Did Saylor just violate his own "sell a kidney" mantra? Strategy's first-ever bitcoin-native sale briefly pushed Bitcoin to $72,000; Jim Cramer questions the bull case

Michael Saylor may be walking back his long-running "sell a kidney" pitch to hold Bitcoin. Strategy disclosed what appears to be its first-ever bitcoin-native sale, a move that briefly sent Bitcoin up to $72,000. CNBC's Jim Cramer said the transaction could prompt investors to rethink Saylor's staunchly pro-Bitcoin posture. The sale surfaced in a newly filed Form 8-K, following on-chain transfers tied to Coinbase Prime.
Selected
BTC
BTC-3.19%
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.